447 related articles for article (PubMed ID: 25922060)
1. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
2. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
3. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
4. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
6. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
7. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.
Cheung YT; Lim SR; Shwe M; Tan YP; Chan A
Value Health; 2013; 16(6):1001-13. PubMed ID: 24041350
[TBL] [Abstract][Full Text] [Related]
9. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
10. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
11. Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors.
Henneghan A; Haley AP; Kesler S
Biol Res Nurs; 2020 Jan; 22(1):126-138. PubMed ID: 31707784
[TBL] [Abstract][Full Text] [Related]
12. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors.
Kesler S; Janelsins M; Koovakkattu D; Palesh O; Mustian K; Morrow G; Dhabhar FS
Brain Behav Immun; 2013 Mar; 30 Suppl(0):S109-16. PubMed ID: 22698992
[TBL] [Abstract][Full Text] [Related]
13. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
[TBL] [Abstract][Full Text] [Related]
14. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
15. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
[TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
18. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
19. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Zhao J; Zuo H; Ding K; Zhang X; Bi Z; Cheng H
Am J Transl Res; 2020; 12(6):3046-3056. PubMed ID: 32655829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]